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In mammalian ovaries, many immature follicles remain after the dominant follicles undergo ovulation. Here we
report the successful production of rabbit embryonic stem cells (ESCs) from oocytes produced by in vitro culture
of immature follicles and subsequent in vitro maturation treatment. In total, we obtained 53 blastocysts from
oocytes that received intracytoplasmic sperm injection followed by in vitro culture. Although only weak ex-
pression of POU5f1 was observed in the inner cell masses of in-vitro-cultured follicle-derived embryos, repeated
careful cloning enabled establishment of 3 stable ESC lines. These ESC lines displayed the morphological
characteristics of primed pluripotent stem cells. The ESC lines also expressed the pluripotent markers Nanog,
POU5f1, and Sox2. Further, these ESCs could be differentiated into each of the 3 different germ layers both in
vitro and in vivo. These results demonstrate that immature follicles from rabbits can be used to generate ESCs.
Moreover, the use of rabbit oocytes as a cell source provides an experimental system that closely matches human
reproductive and stem cell physiology.
Introduction
One major factor limiting the applicability of embry-onic stem cells (ESCs) is the insufficient supply of com-
petent oocytes. In women, a limited number of germ cells are
formed before birth and their number and quality decline
with age. For example, in humans *300,000 primordial fol-
licles are present in the ovary at puberty, but only 300–500
competent oocytes are generated during a fertile lifetime. In
each menstrual cycle, multiple immature follicles are re-
cruited for development simultaneously and usually only a
dominant follicle is selected for ovulation meanwhile the de-
veloping remnants undergo atresia [1–3]. If the immature
follicles that remain after ovulation are made available, then
wemight gain an attractive supply of oocytes that can be used
for stem cell research.
In vitro ovarian follicle culture has been used to produce
developmentally competent oocytes from immature follicles
isolated from mouse [4] and bovine ovaries [5,6]. In other
species it is possible for embryos to develop to morula or
blastocyst stages following in vitro culture of immature fol-
licles [7–12]; however, these embryos do not progress to later
developmental stages.
Recently, it was reported that mouse ESC lines could be
established from oocytes obtained from immature follicles. In
these studies, the oocytes were cultured in vitro, subse-
quently maturated [in vitro maturation (IVM)], and finally
either fertilized in vitro or parthenogenetically activated [13–
15]. If these technologies can be translated to other mam-
malian species, ESC use may become more widespread and
progressive in medical/clinical research and in the livestock
industry. However, there are currently no reports of suc-
cessful ESC production from immature follicle cultures, ex-
cept in mice.
A number of recent studies have provided evidence that
there are dramatic differences between mouse ESCs and hu-
man ESCs [16–18]. For example, mouse ESCs form dome-
shaped colonies and require leukemia inhibitory factor (LIF)
to maintain their pluripotency. In contrast, human ESCs form
flat colonies and undergo basic fibroblast growth factor
(bFGF)-MEK/Erk- and Activin-Smad-dependent self-
renewal. At present, 2 stem cell types have been defined: one
being the naive type (eg, mouse ESCs) and the other being the
primed type (eg, human ESCs) [17]. Therefore, it is usually
assumed that the results obtained from mouse studies cannot
be extrapolated to humans. Thus, it is essential to develop
technologies to generate, characterize, and utilize ESCs from
species that show human-ESC-type characteristics.
Some recent studies have established that rabbit ESCs
express human-ESC-like phenotypes in terms of colony
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morphology, expression of specific markers, and dependence
on bFGF-MEK/Erk and Activin-Smad signaling for mainte-
nance of pluripotency [19,20]. Moreover, rabbits have been
used frequently as models for human osteoarticular [21,22],
circulatory [23,24], and metabolic disorders [25,26]. Further,
there are some practical advantages associated with rabbit
models. Their larger body size enables certain surgical op-
erations to be performed that are not possible with smaller
rodents, such as mice and rats. Additionally, rabbits can be
housed without the need for large expensive facilities that
are required for other animal species that possess pluripotent
stem cells with human-like characteristics (eg, pigs and
monkeys). Therefore, the rabbit model is currently consid-
ered one of the most useful models for stem cell research [27].
In this report, we demonstrate that rabbit ESC lines can be
generated from embryos produced by intracytoplasmic
sperm injection (ICSI) and IVM of oocytes obtained from in
vitro culture of immature rabbit ovarian follicles.
Materials and Methods
Animal use and care
All animal use complied with the regulations of the In-
stitutional Animal Use and Care Committee of the Kinki
University (IACUC, No. KABT-20-003). Each rabbit was
housed in an individual pen with food and water ad libitum.
Animals were exposed to an artificially controlled light–dark
regime with 14 h of lighting and 10 h of darkness. Tem-
perature was maintained between 20C and 25C in a ven-
tilated room.
Collection of ovarian follicles, in vitro culture,
and IVM
Female New Zealand White rabbits (Kitayama Labes Co.
Ltd., Nagano, Japan) were superovulated by a subcutaneous
injection of 80 IU of pregnant mare serum gonadotropin
(PMSG; Sankyo Life Tech, Kanagawa, Japan) and then in-
travenously administered 60 IU of human chorionic gonado-
tropin (hCG; Teikoku Zoki, Tokyo, Japan) 72h later. Rabbit
ovaries were recovered 14h after the hCG injection. Follicles of
200–399mm in diameter at pre-antral to early antral stages were
removed from the ovarian surface using a scalpel. To perform
in vitro culture, oocyte-cumulous/granulosa cell complexes
(OCGCs; Fig. 1A) were recovered from the follicles using 26-
gauge needles (Fig. 1B). In our previous study, we confirmed
that follicles <399mm in diameter collected from rabbit follicles
did not possess competence to resume meiosis after IVM
without in vitro follicle culture [28]. Follicles <200mm in di-
ameter were too difficult to isolate without causing damage
and could not be dissected for in vitro OCGC culture.
OCGCs were cultured individually in 50mL droplets of
follicle culture medium consisting of 0.05% fetal calf serum
(FCS; Hyclone; Thermo Fisher Scientific, Waltham, MA), a-
minimum essential medium (Invitrogen, Carlsbad, CA),
3mg/mL bovine serum albumin (Sigma-Aldrich, St.
Louis, MO), 50 mg/mL ascorbic acid (Sigma-Aldrich), 1%
antibiotic/antimycotic solution (Sigma-Aldrich), and 1%
insulin-transferrin-selenium-A solution (Invitrogen) under
mineral oil at 37C in a humidified atmosphere of 5%CO2 and
95% air for 8 days.Medium refreshment was performed every
day. For inducing resumption of meiosis, denuded oocytes
were transferred into 50 mL drops of maturation medium
consisting of TCM 199 (Nissui Pharmaceutical, Tokyo, Japan),
0.2724mg/mL water-soluble b-estradiol (Sigma-Aldrich),
0.1mg/mL polyvinyl alcohol (average molecular weight
30,000–70,000; Sigma-Aldrich), and 10 ng/mL epidermal
FIG. 1. Morphology of follicles and cultured oocytes. (A)
Isolated follicles were selected based on their diameter (200–
399mm). The white arrow marks the location of the immature
follicular antrum. (B) OCGCs extracted from the follicles and
imaged before culturing. (C) OCGCs after 8 days of culture.
(D) Denuded oocytes collected from the precultured OCGCs.
Arrow shows the germinal vesicle stained by DAPI. (E) De-
nuded oocytes at metaphase II stage collected after 8 days of
OCGC culture and subsequent IVM. Black arrow points to the
first polar body and white arrow points to the nucleus of the
oocyte. (F) Fertilized oocytes after ICSI. (G) Blastocyst em-
bryos obtained by OCGC culture, IVM, ICSI, and culture.
Scale bars = 100mm. OCGCs, oocyte-cumulous/granulosa
cell complexes; IVM, in vitro maturation; ICSI, in-
tracytoplasmic sperm injection.
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growth factor (Sigma-Aldrich) and cultured for 16 h at 37C in
a humidified atmosphere of 5% CO2 and 95% air.
ICSI and embryo culture
ICSI has been well established in rabbits [29]. For oocytes
that develop in vitro, it is necessary to assess their stage, that
is, germinal vesicle (GV), metaphase I (MI), or metaphase II
(MII) stage. To make such an assessment, granulosa/
cumulus cells must be denuded. Therefore, conventional in
vitro fertilization (IVF) was not appropriate for our study.
Seminal fluid was obtained from fertile male Dutch Belted
rabbits (Kitayama Labes Co. Ltd.) using an artificial vagina.
The seminal fluid was washed once in 5mL of M2 medium
followed by centrifugation at 750 rpm for 1min. Medium
was aspirated from the resulting sperm pellet that sank to the
bottom in 2mL of fresh M2 medium. Sperm that were ca-
pable of swimming upward from the pellet were selected
and transferred to fresh M2 medium. Microinjection was
conducted using a piezo-driven micromanipulation system
(PRIME Tech Ltd., Ibaraki, Japan). The sperm that had
translatory movement were transferred to 10% poly-
vinylpyrrolidone (SIGMA) and the sperm heads were iso-
lated. The oocytes were positioned on the microinjection
system with the first polar body at either 6 or 12 o’clock. An
injection needle was then inserted at 3 o’clock and pushed
across 3-quarters of the oocyte diameter to puncture the
oocyte membrane by faint piezo-pulse. An isolated sperm
head was then gently injected into the ooplasm.
Injected oocytes were washed twice in 50 mL drops of
CMRL1066 medium (Invitrogen) supplemented with 30%
FCS (Thermo Fisher Scientific K.K.), 0.55mg/mL sodium
pyruvate (SIGMA), 0.146mg/mL l-glutamine (SIGMA),
1.861mg/mL lactate (SIGMA), 0.063mg/mL penicillin G
potassium salt (Nacalai tesque, Kyoto, Japan), and 5.0 mg/
mL gentamicin solution (SIGMA). The oocytes were then
transferred into 50mL drops of CMRL1066 complete medium
under mineral oil and cultured for 5 days at 38C in a hu-
midified atmosphere of 5% CO2, 5% O2, and 90% N2 in air.
The fertilization rates, cleavage rates, and blastocyst forma-
tion rates were checked 6–8, 24, and 120 h after ICSI.
Establishment of the ESCs
Inner cell masses (ICMs) were obtained from blastocysts
using immunosurgery. After removal of the zonapellucidae
by treatment with 0.05% Pronase (Roche Diagnostics, Basel,
Switzerland), embryos were cultured in 50mL of 10% FBS-
DMEM containing 5mL of anti-rabbit guinea pig anti-serum
for 20min. The embryos were then transferred to 50mL of
guinea pig serum for 20min. The isolated ICMs were indi-
vidually seeded onto mitomycin-C-treated (10mg/mL in me-
dium for 90min; Invitrogen) mouse embryonic fibroblast
(MEF) feeder cells and cultured in rabbit ESC medium (ESM)
consisting of 20% Knockout serum replacement (Invitrogen),
DMEM/F12 (Invitrogen), 2mM l-glutamine (Wako Pure
Chemical Industries, Tokyo, Japan), 1% nonessential amino
acids (Invitrogen), 0.1mM b-mercaptoethanol (Invitrogen),
and 8ng/mL human recombinant bFGF (Wako Pure Che-
mical Industries) for 10 days. After 10 days of culture, cells
originating from outgrowth of the ICM were collected using a
sterile glass capillary (Drummond Scientific Company, Broo-
mall, PA), treated with CTK colony-dissociation solution [30],
and dissociated to small cell clumps containing about 10–20
cells. The cell clumps were washed once in ESM, transferred
to fresh feeder layers, and cultured in ESM for an additional 6
days. When the cells showed ESC-specific morphology (ie,
small size and a high nuclear/cytoplasmic ratio), the area
containing the pluripotent stem cells was isolated using the
sterile glass capillary, and dissociated and passaged as de-
scribed previously. These procedures were repeated*6 times
until homogeneous undifferentiated colonies were obtained.
When the ESCs reached a stable proliferation rate with
homogenously undifferentiated cell populations, they were
maintained under standard conditions and passaged using
CTK colony-dissociation solution as previously reported [20,30].
The rabbit ESCs (rESCs) generated by follicle culture, IVM,
ICSI, and embryo culture are herein referred to as ‘‘fESCs.’’
Table 1. Primary Antibodies Used in Immunofluorescence, Western Blot Analysis, and Immunohistochemistry
Antibody Company Dilution
Specific
band (kDa)
Actin (sc-1616) Santa Cruz Biotechnology 1/5,000 in 10% Block Ace/0.2% Tween-TBS 43
SSEA1 (sc-21702) Santa Cruz Biotechnology 1:100 in PBS containing 10% Block Ace Not performed
SSEA4 (sc-21704) Santa Cruz Biotechnology 1:100 in PBS containing 10% Block Ace Not performed
POU5f1 (sc-8628) Santa Cruz Biotechnology 1/200 (IF) or 1/5,000 (WB) in 0.2% Tween-TBS
containing 10% Block Ace
45
Klf4 (sc-20691) Santa Cruz Biotechnology 1/3,000 in 0.2% Tween-TBS containing 10%
Block Ace
55
Sox2 (sc-17320) Santa Cruz Biotechnology 1/1,000 in Can Get Signal (Toyobo Life science,
Tokyo, Japan)
34
Neuron-specific class III
b-tubulin (TU-20)
Millipore 1/200 in 0.2% Tween-TBS containing 10%
Block Ace
Not performed
Desmin (E-2571) Spring Bioscience
(Pleasanton, CA)
1/100 in 0.2% Tween-TBS containing 10%
Block Ace
Not performed
Cardiac troponin-T
(sc-6243)
Santa Cruz Biotechnology 1/200 in Immuno-enhancer Not performed
a-Fetoprotein (N-1501) DAKO JAPAN 1/200 in 0.2% Tween-TBS containing 10%
Block Ace
Not performed
IF, immunofluorescence; WB, western blot analysis.
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Immunofluorescence evaluation
The cell cultures were fixed with Mildform 10N (Wako
Pure Chemical Industries) at room temperature for 1 h. Fixed
cells were washed with PBS, blocked with Block Ace (Dai-
nippon Sumitomo Pharma, Osaka, Japan) for 1 h, washed
twice more, and incubated with each primary antibody
(Table 1) overnight at 4C. The samples were then washed
twice and incubated with secondary antibodies (FITC or
Texas red-conjugated polyclonal antibodies; all were pur-
chased from Santa Cruz Biotechnology, Santa Cruz, CA).
Samples were counterstained with DAPI (1 mg/mL in PBS)
prior to direct observation. Negative controls were prepared
omitting the primary antibodies (data not shown).
Western blot analysis
Cells were collected by scraping, homogenized in SDS buffer
(4% SDS, 125mM tris-glycine, 10% 2-mercaptoethanol, and 2%
bromophenol blue in 30% glycerol), and then subjected to
polyacrylamide gel electrophoresis (PAGE) in the presence of
SDS (SDS/PAGE), followed by electrotransfer onto PVDF
membranes (Hybond-P; Amersham Pharmacia Biotech, Buck-
inghamshire, United Kingdom). Feeder layers (MEF) were
used as a negative control. The blotted membranes were
blocked overnight with Block Ace (Dainippon Pharmaceutical,
Osaka, Japan) and treated with each primary antibody (Table 1)
overnight at 4C. Detection was realized by enhanced chemi-
luminescence with an ECL plus western blotting detection
system (Amersham Pharmacia Biotech) and horseradish per-
oxidase (HRP)–conjugated secondary antibodies (all were
purchased from Santa Cruz Biotechnology) corresponding to
each primary antibody. The lumino-labeled membranes were
analyzed using an LAS 4000 CCD-based chemiluminescent
analyzer (Fujifilm, Tokyo, Japan).
RNA extraction, RT-PCR, and quantitative real-time
polymerase chain reaction
Total RNA was extracted using TRIzol reagent (Invitro-
gen) according to the manufacturer’s instructions. One mi-
crogram of total RNA was used for cDNA synthesis with
random hexamers. Products were filled up to 100 mL with
Tris-EDTA (TE), and used at 1 mL per reaction for RT-PCR or
quantitative real-time PCR (qRT-PCR). RT-PCR was carried
out using a Thermal Cycler Dice (Takara Bio, Inc., Shiga,
Japan). Nanog, POU5f1, Sox2, and GAPDH amplifications
were performed with a denaturation step at 95C for 10min,
followed by 35 cycles of denaturation at 95C for 20 s, primer
annealing at 58C for 20 s, and extension at 72C for 20 s.
qRT-PCR was carried out using Perfect real-time SYBR green
II (Takara Bio, Inc.) with rabbit-specific primers (Table 2) in a
Thermal Cycler Dice Real Time System (Takara Bio, Inc.).
Reactions were performed with a denaturation step at 95C
for 30 s, followed by 40 cycles of denaturation at 95C for 5 s
and primer annealing and extension at 60C for 30 s. Reac-
tions were run in duplicate in 3 independent experiments. To
quantify the relative expression of each gene, Ct (threshold
cycle) values were normalized to an endogenous reference
(DCt=Ct target – Ct internal control) and compared with the
mean score from the calibrator (control sample) using the
DDCt method (DDCt =DCt sample – DCt mean of calibrator).
The mean score of the 28sRNA housekeeping gene was used
as an internal control to normalize the variability in expres-
sion levels because of its sensitivity. Stability of gene ex-
pression across cell lines and validation of the internal
control are provided in Supplementary Fig. S1 (Supplemen-
tary Data are available online at www.liebertpub.com/scd).
For comparison of pluripotency-related gene expression
levels between the ICMs from in vitro follicular-culture-
derived embryos and the ICMs from control embryos, ICMs
were paired to increase the total amount of RNA available
for analysis. ICMs were collected by immunosurgery as de-
scribed previously, and 3 pairs (in total 6 blastocysts) were
analyzed for each group. For qRT-PCR of ICMs, quantifica-
tion of total RNA was not performed and all extracted RNA
was used for reverse transcription. In this experiment, cDNA
products were filled up to 20mL in TE and used at 1 mL per
reaction for qRT-PCR.
For comparison of pluripotency-related gene expression
levels between fESCs and normal ESCs, we used 2 previ-
ously established normal rabbit ESC lines [20]. The normal
ESCs and the fESCs were cultured on feeder layers in ESM
supplemented with bFGF for 72 h after passaging. ESC col-
onies were collected using CTK colony-digestion solution
and treated with TRIzol reagent for RNA isolation.
Inhibitor-based determination of the signaling
cascades related to pluripotency maintenance
in fESCs
Confluent fESCs were passaged onto Matrigel (BD Falcon,
Bedford, MA) and cultured in MEF-conditioned rESC-medium
(rESM) for 24h to eliminate feeder cells. The medium was then
replaced with rESM containing 8ng/mL bFGF, 1,000U/mL
LIF (Millipore, Billerica, MA), and 20% MEF-conditioned me-
dium. For inhibition of signal transduction, 1mM JAK inhibitor
I (Merck, Darmstadt, Germany), 1mM MEK/Erk inhibitor
PD0325901 (Stemgent, Cambridge, MA), or 0.5mM ALK4/5/7
inhibitor A83-01 (Stemgent) was added to the culture medium.
After 48h, cultures were collected and analyzed for the plur-
ipotency marker gene Nanog using qRT-PCR.
Evaluation of multiple differentiation potentials
For in vitro differentiation, fESC colonies were collected
with CTK solution, washed once with fresh ESM, and then
Table 2. Primer Sequences Used in RT-PCR
and Quantitative Real-Time Polymerase
Chain Reaction
Primer name Primer sequence (5¢-3¢)
28s rRNA FOR AGCAGAATTCACCAAGCGTTG
28s rRNA REV TAACCTGTCTCACGACGGTC
POU5f1 FOR GATCACTCTGGGCTACACTC
POU5f1 REV AGATGGTGGTTTGGCTGAAC
Sox2 FOR GAGTGGAAACCCTTGTGG
Sox2 REV ATTTATAACCCTGTGCTCCTCC
Nanog FOR TAGTGAAAACTCCCGACTCTG
Nanog REV AGCTGGGTCTGGGAGAATAC
Klf4 FOR AGGAGTCCAAGCCAAAGAG
Klf4 REV AATCGGAAGTGTGGGTG
GATA6 FOR AGTGCGTGAACTGCGGCTC
GATA6 REV TGAAGGCACGCGCTTCTG
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transferred into suspension culture in 10% FCS–supple-
mented DMEM (Invitrogen). After 6 days in suspension
culture, embryoid bodies (EBs) formed from the fESCs were
collected and replated onto gelatin-coated culture dishes.
The cells derived from the EBs were evaluated by immuno-
fluorescent staining with specific antibodies following 10
days in culture.
Differentiation properties of the fESCs were evaluated
in vivo via teratoma formation assay. Cell suspensions con-
taining 5· 106 fESCs were subcutaneously injected into the
femora of severe combined immunodeficient (SCID) mice.
After 8 weeks from the time of cell injection, teratomas were
collected, fixed by Mildform 10N (Wako Pure Chemical In-
dustries) overnight at room temperature, dehydrated, and
embedded in paraffin.
Immunohistochemical staining
Immunohistochemical (IHC) staining was performed on 6-
mm-thick deparaffinized sections. Endogenous peroxidase
activity was blocked using 0.3% hydrogen peroxide. Next,
the sections were blocked with Block Ace and incubated with
primary antibodies (Table 1) overnight at 4C. After wash-
ing, HRP-conjugated secondary antibodies were applied,
and samples were further incubated for 30min at room
temperature. Finally, the slides were visualized by DAB
immunostaining using the Liquid DAB + substrate Chro-
mogen System (DAKO JAPAN, Kyoto, Japan).
Statistical analysis of the data
In experiments comparing gene expression levels between
ICMs, scores obtained by DDCt calculations were analyzed
by Student’s t-test. For comparing gene expression levels
between ESC lines, scores obtained by DDCt calculations
were analyzed by Tukey–Kramer HSD test or Student’s t-
test. Both statistical analyses were performed with JMP
software version 7.0.2 (SAS Institute, Cary, NC). P-values
< 0.05 were considered significant.
Results
Production of MII oocytes, blastocysts, and ESCs
by in vitro follicle culture, IVM, ICSI, and ICM culture
We obtained 264 MII oocytes from 349 early antral follicles
(75.6%). All oocytes included in the preculture follicles were
FIG. 2. Analysis of pluripotency-related gene expression in the fICMs. (A) Quantitative real-time polymerase chain reaction
gene expression analysis for characterization of fICMs. Bars show the mean score of 3 independent experiments and error
bars depict S.D. Asterisks indicate significant differences (P < 0.05) between experimental groups. (B) Immunofluorescent
observation for POU5f1 expression in the ICMs cultured on the MEF feeder layer. White broken lines show ICM-derived
regions. Arrows show the first points where ICMs attached. Scale bars= 500 mm. (C) Immunofluorescent observation for
POU5f1 expression in the ICM-derived cells at passage 4. Arrow shows the undifferentiated region of the fICM outgrowth.
Scale bars = 200 mm. ICMs, inner cell masses.
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in GV stage when evaluated by nuclear staining with DAPI
(Fig. 1D), and these proceeded to MII stage after in vitro
culture and IVM (Fig. 1E). After ICSI and embryo culture, 53
embryos reached the blastocyst stage (20.1%, from MII oo-
cytes). These blastocyst embryos were morphologically nor-
mal, and some of them hatched at the end of the culture
period (Fig. 1G). We isolated ICMs from the blastocysts by
immunosurgery. In total, 24 ICMs were collected.
We first examined whether ICMs obtained from follicular-
culture-derived embryos (fICMs) possessed the pluripo-
tency necessary for establishment of ESC lines. To confirm
pluripotency, we performed real-time PCR analysis for
genes related to pluripotency using ICMs collected by im-
munosurgery. No statistically significant differences were
observed for Nanog, Sox2, and Klf4 expression; however, the
expression of the pluripotency-related gene POU5f1 was
significantly lower and the early differentiation marker
GATA6 expression was significantly higher in fICMs (Fig.
2A). To examine the possibility that differential gene ex-
pression of POU5f1 might influence the appearance of un-
differentiated cells, we performed in vitro culture of ICMs
on MEF feeder layers and observed POU5f1 expression
levels. After 4 days in culture, ICMs exhibited growth and
expansion out of the ICMs. Although no significant mor-
phological differences were observed between the fICMs
and the control ICMs, observation of immunofluorescence
revealed that POU5f1 was expressed at lower levels in
fICMs (Fig. 2B). In control ICMs, many POU5f1-expressing
cells appeared at the initial ICM attachment point as well as
in the outgrowth regions. In fICMs, on the other hand, only
a few POU5f1-expressing cells emerged in the center area of
the original ICM cell clump and even fewer were observed
in the outgrowth regions. After isolation of the undiffer-
entiated areas from the cultured fICMs, cells were passaged
onto fresh feeder layers. These cells gave rise to very het-
erogeneous colonies consisting of many differentiated cells
and a few undifferentiated cells (Fig. 2C). This high het-
erogeneity continued during early passages at least up to
passage 6. However, continued careful cloning enabled es-
tablishment of stable undifferentiated cell lines. In total, 3
stable cell lines were established from 24 fICMs by this
method.
Evaluation of fESC pluripotency
To evaluate the pluripotency of fESCs, we performed an
ALP activity assay, as well as immunofluorescence, RT-PCR,
and western blot analyses. All 3 cell lines formed flat colonies
FIG. 3. Characterization of the fESCs. (A) All fESC lines exhibited intense alkaline phosphatase (ALP) activity and labeled
with POU5f1, SSEA1, and SSEA4 antibodies. Scale bars= 100mm. (B) All fESC lines also expressed pluripotent cell markers.
RT-PCR analysis provides additional evidence for Nanog, POU5f1, and Sox2 gene expression in the fESCs. (C) Western blot
(WB) analysis shows Klf4, POU5f1, and Sox2 protein expression in the fESCs. ESCs, embryonic stem cells.
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and individual cells exhibited prominent nuclei. All 3 cell
lines showed high ALP activity and expressed the pluripo-
tent cell markers POU5f1, SSEA1, and SSEA3 (Fig. 3A). RT-
PCR analysis and western blot analysis confirmed that the
fESCs expressed these markers. Nanog, POU5f1, and Sox2
were detected by RT-PCR (Fig. 3B) and Klf4, POU5f1, and
Sox2 were detected by western blot (Fig. 3C). Nanog could
not be detected by western blot because there were no spe-
cific antibodies available for rabbit Nanog protein. We then
compared expression levels of the pluripotent-related genes
FIG. 4. Quantitative real-time
polymerase chain reaction gene ex-
pression analysis for characteriza-
tion of fESCs. (A) Comparison of
expression levels of pluripotent cell
markers among normal rabbit ESCs
and fESCs. Bars show the mean
score of 3 independent experiments
and error bars depict S.D. (B) Ana-
lysis of signal transduction path-
ways related to fESC self-renewal.
The 3 fESC lines are represented by
#1, #2, and #3. All culture condi-
tions contained MEF conditioned
medium. JAK-i means JAK inhibi-
tor 1, MEK-i means MEK inhibitor,
and ALK-i means ALK inhibitor.
Bars show the mean score of 3 in-
dependent experiments and error
bars depict S.D. Letters indicate
significant differences (P < 0.05) be-
tween experimental groups.
FIG. 5. Embryoid body (EB)–
mediated in vitro differentiation of
fESCs. All panels show images of
differentiated cells 10 days after EB
attachment. TuJ-expressing neural
cells (left), a-fetoprotein-expressing
endodermal cells (middle), and
Desmin- and cardiac troponin T–
expressing cardiac myocyte (right)
are shown. Scale bars= 200mm.
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Nanog, POU5f1, and Sox2 among the fESCs and the 2 normal
rabbit ESC lines at passages 20 to 24. The expression levels
were the same among the normal rabbit ESCs and the 3 fESC
lines (Fig. 4A).
Next, we blocked 3 independent signal transductions
pathways related to ESC self-renewal to determine which
signaling cascades were required to maintain fESC plur-
ipotency. Nanog expression was lower for fESCs cultures
treated with LIF, than that for fESCs cultures treated with
bFGF. We next cultured fESCs in MEF-conditioned medium
containing both bFGF and LIF and 1 of 3 inhibitors: either a
JAK inhibitor to block LIF-JAK-Stat3 signaling, a MEK in-
hibitor to block bFGF-MEK/Erk signaling, or an ALK in-
hibitor to block Activin-Smad signaling. JAK inhibition did
not affect Nanog expression, whereas MEK or ALK inhibi-
tion caused a significant decrease in Nanog expression.
Combined application of MEK and ALK inhibitors resulted
in even lower expression of Nanog. These results demon-
strate that our fESCs rely on LIF-independent signaling
pathways that involve both bFGF-MEK/Erk signaling and
Activin-Smad signaling to maintain their pluripotency,
similar to what has been observed for other rabbit ESCs
and human ESCs (Fig. 4B).
fESCs possess multiple differentiation potentials
both in vitro and in vivo
To analyze the differentiation potential of the fESCs, we
performed suspension culture to induce EB formation. After
6 days in suspension culture, the ESCs formed cystic EBs.
Ten days after attachment to culture dishes, the EBs differ-
entiated into various types of cells, including fibroblasts,
neurons with axons, and beating cardiac cells. Immuno-
fluorescent analysis using anti-TuJ, anti-a-fetoprotein, anti-
desmin, and anti-cardiac troponin T antibodies revealed that
neural cells, endodermal cells, and cardiac myocytes were
formed from each of the 3 fESC lines (Fig. 5). To test this
in vivo, we transplanted 2 fESC clones (#1 and #2) into the
femurs of SCID mice. In all cases, solid teratoma formation
was observed after 8 weeks. Hematoxylin-eosin stain (HE)
staining and IHC staining revealed that these teratomas
contained various tissues derived from all 3 germ layers,
such as epidermal tissues (ectoderm), TuJ-expressing neural
tissues (ectoderm), desmin-expressing muscular tissues
(mesoderm), and intestinal epithelium (endoderm) (Fig. 6).
Discussion
To provide another valuable source of oocytes for clinical
use and research, it is necessary to examine the potency of
the ovarian follicle. Here, we demonstrated that it is possible
to establish ESC lines from immature ovarian follicles in
rabbits. By using postovulated ovaries treated with gonad-
otropins, we think it may be possible to extrapolate some of
our results to humans, where oocytes are typically collected
following superovulation, although further studies will be
required to verify this assertion. At the end of the study, we
established fESCs that met the evaluation criteria for rabbit
undifferentiated ESCs; that is, they exhibited ALP activity
and expressed SSEA1, SSEA3, and a variety of other plu-
ripotent markers. The fESCs were capable of differentiating
into 3 different germ layers both in vitro and in vivo. This is
the first report of ESC production from immature follicular
oocytes obtained from postovulated ovaries in a nonmouse
species. As described earlier, rabbit ESCs seem to possess
human-type pluripotent stem cell–like characteristics at least
in terms of colony morphology, marker expression, and
signal transduction pathways essential to maintain plur-
ipotency. Therefore, the fact that the ESCs established from
ovarian follicular oocytes are obtainable from rabbits is im-
portant for the stem cell research field.
We recently developed a method for obtaining oocytes that
develop to the blastocyst stage from rabbit ovarian follicles via
in vitro follicle culture [28]; therefore, we attempted to utilize
this system for establishing ESCs. First, we determined the
pluripotency of cells in rabbit ICMs following immunosurgical
isolation using qRT-PCR for pluripotency-related genes. We
found that the expression level of POU5f1 was significantly
lower in ICMs from follicular-oocyte-derived embryos. Sub-
sequent experiments showed that this low level of POU5f1
expression was carried over through early passages in vitro for
ICMs cultured on MEF feeder layers. The fICMs gave rise to
very heterogeneous populations of cells, including many dif-
ferentiated cells. It should be noted, however, that this phe-
nomenon usually does not occur during establishment of ESC
lines, even from control (normal) embryos.
FIG. 6. Histological evaluation of teratomas derived from
the fESCs (#1 and #2). Images show epidermal tissues, TuJ-
expressing neural tissues (immunohistochemistory; IHC),
Desmin-expressing muscular tissues (IHC), and intestinal
epithelium (HE). Scale bars = 200mm.
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Until now, it has been accepted that POU5f1 (also known
as Oct4) expression persists throughout peri-implantation
development as a major factor involved in regulating plur-
ipotency [31–34]. In mouse embryo development, Oct4 ex-
pression competes with Cdx2 to determine the fate of cells
[ICM or trophectodermal cell (TE) fates]. Reduced Oct4 ex-
pression results in enhanced Cdx2 expression, committing
cells to the TE fate [31,35]. However, some reports suggest
that the contradictive relationship between Oct4 and Cdx2
may be species specific. For example, Harvey et al. moni-
tored expression patterns of Oct4, Nanog, and Cdx2 in
blastocysts from cynomolgus monkeys and did not observe a
contradictive relationship between Oct4 and Cdx2 [36]. In
our study using rabbits, Cdx2 expression was not detected in
the fICMs, even though relatively low levels of POU5f1 ex-
pression were observed, suggesting that Oct4 and Cdx2 may
also not follow a contradictive relationship in rabbits. Re-
cently, Kobolak et al. analyzed expression of rabbit POU5f1
in detail. They reported that POU5f1 is expressed in the TE in
addition to the ICM [37]. This expression pattern was similar
to other mammalian models, including monkey, porcine,
and bovine, although expression of POU5f1 was much
higher in the ICM. Interestingly, it has also been demon-
strated that if Oct4 is removed from Cdx2-KO mouse ESCs,
then the ESCs initiate differentiation [31]. This clearly indi-
cates that Oct4 has important functions besides determina-
tion of cell fate between ICM cells or TE cells in combination
with Cdx2.
Oct4 is part of the pluripotency-maintaining core circuit
with Nanog and Sox2 [33,38]. Nanog and Sox2 are also ex-
pressed in the ICM and act as important elements for es-
tablishment and control of pluripotency. However, at least 3
facts obscure the indispensability of Sox2 and Nanog in es-
tablishment of pluripotency. First, deletion of Sox2 can be
partially compensated for by other Sox family members,
such as Sox4, Sox11, and Sox15 [32,39,40]. Second, forced
expression of Oct4 can rescue the loss of pluripotency in
ESCs triggered to differentiate by Sox2 deletion [32]. Finally,
pluripotency of mouse ESCs can be maintained even if Na-
nog is removed [33,41]. From these 3 lines of evidence, Oct4
function can be thought of as the most important factor in-
volved in pluripotency. Thus, it is likely that the POU5f1
(Oct4) depletion observed in our system may directly alter
the outgrowth of ICM cells, resulting in heterogeneous cell
populations containing many differentiated cells.
Once the undifferentiated cells were isolated by repeated
cloning and entered a stable cycle of self-renewal, they ex-
pressed pluripotent cell markers at comparable levels to
normal rabbit ESCs and could be stably maintained for at
least 50 passages. Recently, it was reported that heteroge-
neous populations of ESCs contain at least 3 types of cells
[42,43]. Pluripotent cells, differentiated (or differentiating)
cells, and transitory cells can appear in the same culture and
the frequency at which they appear can vary according to
culture conditions and cell origins. If these findings from
mouse ESCs are also applicable to rabbit ESCs, then it is
highly possible that the ESC lines we established were the
result of multiple selections for undifferentiated cells.
After entering a phase of stable proliferation, no signifi-
cant differences in gene expression levels were observed for
pluripotent cell markers among the fESC lines and the 2
normal rabbit ESC lines. To permit comparison of plur-
ipotency among all 5 cell lines (3 fESCs and 2 rESCs), we
maintained the cells on feeder layers. This prevented bias
due to differential vulnerability of cell lines to feeder-free
culture. All fESC lines showed higher expression levels of the
pluripotent marker genes than that of somatic cells, although
the variation in expression level was somewhat large. This
large variation can be attributed to unavoidable factors, such
as contamination with feeder cells or unevenness in quality
of the feeder layers. There are 2 possible reasons why the
fESCs showed comparable pluripotency gene expression to
control ESCs. Either cloning-mediated selection of the ESCs
possessing typical ESC characteristic as described previously
or alteration of the epigenetic status of the cells may have
occurred. In mouse and human ESCs, epigenetic status can
be affected by in vitro culture [44]. Surprisingly, Horii et al.
reported that epigenetic modification can occur within as
few as 5 passages, over which time differences in expression
patterns between ESCs established from embryos produced
via IVF and in ESCs from in vivo embryos can disappear
[45]. In our study, it is possible that in vitro culture of the
fESCs altered their epigenetic profile, resulting in expression
characteristics that were comparable to control ESCs.
To determine whether the pluripotency of the fESCs was
of a primed pluripotent form, we performed signal trans-
duction blocking studies. These studies demonstrated that
the fESCs maintained pluripotency through bFGF-MEK/Erk
and Activin-Smad signaling mechanisms characteristic of
normal rabbit ESCs and other primed-form ESCs. To isolate
the effects of inhibitors on fESCs, the fESCs were first
transferred into feeder-free conditions. Reactivity of the
fESCs to inhibitors was generally consistent, but subtle dif-
ferences between cell lines were observed. It is possible that
the fESC lines possessed a diverse range of characteristics in
terms of sensitivity to the presence of cytokines or signal
transduction inhibitors, similar to what has been observed
for human ESCs, in which the reactivity to Activin varies
among ESC lines [46]. Based on the fact that the fESCs
showed typical rabbit ESC characteristics, including human-
ESC-like pluripotency [19,20], our results provide important
evidence to support the argument that ovarian follicles could
be a valuable source for ESC generation.
From another viewpoint, our results provide valuable in-
formation about the developmental properties of embryos
produced from in vitro ovarian follicle culture. No viable
newborns have yet been reported from the in vitro culture of
immature follicles from rabbits [28] and it is known that ICM
pluripotency is a prerequisite for fetus formation. Although
limited development to blastocyst stages has been reported
for rabbit embryos, the pluripotency of embryonic ICM cells
has not been confirmed in immature follicular cultures. In
our study, the fact that ESCs could be generated from the
ICMs of rabbit embryos derived from in vitro culture of
immature follicles provides indirect evidence that the ICMs
of embryos produced in follicular culture systems are plu-
ripotent. This finding is important because successful em-
bryo development to the blastocyst stage from ovarian
immature follicular culture systems has been reported for
species that are of importance to the livestock industry and
that can also serve as model systems for reproductive med-
icine, including bovine [5,6], porcine [7,8], and buffalo [9]. In
porcine [47,48] and bovine [49], procedures for obtaining
pluripotent ESCs have already been developed. Further, Xu
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et al. recently succeeded in producing MII oocytes from
immature secondary follicles by in vitro culture [50]. Al-
though it may be difficult to obtain developmentally com-
petent oocytes from primates, the techniques for ESC
production have been well established in these species [51–
53]. Therefore, application of our technique for deriving
ESCs from immature follicles may lead to advancements in
ESC research that are both economically and clinically
important.
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